What does the latest research say about the benefits of GLP-1 drugs?
· 25 min
Episode What does the latest research say about the benefits of GLP-1 drugs?
GLP-1 drugs like Ozempic are proven effective for type 2 diabetes and weight management. Researchers are now exploring their potential to reduce heart, kidney, liver, and even Alzheimer’s disease risks. But experts, including obesity specialist Dr. Sean Wharton, warn against off-label use. He breaks down the latest research and what the future might hold.
For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.
Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.